| Affiliation: | 1. University Hospitals Leuven, Department of Obstetrics and Gynaecology, Leuven, Belgium;2. European Organisation for Research and Treatment of Cancer, Gynecological Cancer Group, Brussels, Belgium;3. Institute of Clinical Trials and Methodology, London, UK;4. Medical Research Council Clinical Trials Unit at University College London, London, UK;5. Norwegian Radium Hospital and Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway;6. Department of Gynecologic Oncology, University of British Columbia, Vancouver, BC, Canada;7. Department of Medical Oncology, Christie Hospital and University of Manchester, Manchester, UK;8. Department of Gynecologic Oncology, Royal United Hospitals Bath, Bath, UK;9. Norwich Clinical Trials Unit and Norwich Medical School, University of East Anglia, Norwich, UK;10. Department of Gynecological Oncology, Vrije Universiteit Medical Center, Amsterdam, Netherlands;11. Department of Pathology, Queen''s University, Belfast Health and Social Care Trust, Belfast, UK;12. Institute of Cancer and Pathology, St James''s University Hospital, Leeds, UK;13. Department of Gynecology-Obstetrics, University of Rome “Sapienza”, Rome, Italy;14. Department of Gynecological Oncology, Center Gynaecologic Oncology Amsterdam, University of Amsterdam, Amsterdam, Netherlands;15. Department of Medical Oncology, Hospital Universitario San Carlos, Madrid, Spain;p. Department of Medical Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain;q. Department of Clinical Oncology, Beatson Oncology Centre, Glasgow, UK;r. Department of Gynaecological Cancer, University of Birmingham, Birmingham, UK |
